Actinium Pharmaceuticals Inc share price logo

Actinium Pharmaceuticals Inc

NYSE: ATNM

Small Cap

$1.24

-0.02

(-1.59%)

as on

Actinium Pharmaceuticals Inc Stock Performance

as on May 7, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.23
    $1.30
    downward going graph

    0.81%

    Downside

    4.84%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.95
    $1.95
    downward going graph

    23.23%

    Downside

    56.89%

    Upside

    downward going graph

Actinium Pharmaceuticals Inc share price movements today

Previous Close
$1.26
Open
$1.30
Volume
1.1M
Day's Low - High
$1.23 - $1.30
52 Week Low - High
$0.95 - $1.95

Actinium Pharmaceuticals Inc Historical Returns

1 Month Return
+ 15.6 %
3 Month Return
+ 9.57 %
1 Year Return
-8.7 %
3 Year Return
-85.68 %
5 Year Return
-82.64 %

Actinium Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Actinium Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$39.5M

EPS (TTM)

-0.8867

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-36.1M

Revenue (TTM)

90.0K

Profit Margin

0.00%

Return On Equity TTM

-166.96%

Actinium Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Actinium Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$39.5M-82.64%NA0.00%
BUY$40.2B127.94%75.8512.55%
BUY$107.9B99.08%25.1832.94%
NA$33.1BNA120.445.37%
BUY$73.6B40.83%17.1329.65%

Stock Returns calculator for Actinium Pharmaceuticals Inc Stock including INR - Dollar returns

The Actinium Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Actinium Pharmaceuticals Inc investment value today

Current value as on today

₹1,00,838

Returns

₹838

(+0.84%)

Returns from Actinium Pharmaceuticals Inc Stock

-₹10,145 (-10.14%)

Dollar Impact

₹10,983 (+10.98%)

Analyst Recommendation on Actinium Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Actinium Pharmaceuticals Inc. Average target price of $5

Actinium Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Actinium Pharmaceuticals Inc.

What analysts predicted

75.2%UPSIDE

Target Price

$5

Current Price

$1.24

Analyzed by

12 Analysts

Target

$5.00

Actinium Pharmaceuticals Inc target price $5, a slight upside of 75.2% compared to current price of $1.24. According to 12 analysts rating.

Indian Investors' Interest in Actinium Pharmaceuticals Inc Stock

Search interest for Actinium Pharmaceuticals Inc Stock has increased by 148% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:148% versus previous 30 day period

Actinium Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
0
-
-
-
0
-
-
0
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-14
-10
-9
-12
-12
-7
-16
-7
-5
-6
EBITDA
-13
-10
-9
-11
-11
-6
-15
-6
-4
-6
Interest Expense
-
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-13
-9
-8
-11
-11
-6
-15
-6
-5
-5
Income Tax Expense
0
0
0
-
-11
-
-
-
-
-
Net Income
-13
-9
-8
-11
-11
-6
-15
-6
-5
-5
Net Profit Margin
0.00%
-11511.11%
0.00%
0.00%
0.00%
-821.23%
0.00%
0.00%
-5701.11%
0.00%

Actinium Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
0
1
1
0
-
0
Gross Profit
0
0
0
0
0
0
1
0
0
0
Operating Income
-26
-26
-23
-22
-22
-24
-34
-51
-42
-36
EBITDA
-26
-26
-23
-21
-21
-24
-33
-51
-37
-35
Interest Expense
0
0
0
-
-
0
1
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-24
-26
-23
-21
-22
-24
-33
-48
-38
-33
Income Tax Expense
0
0
0
0
0
0
-1
0
-
-
Net Income
-24
-26
-23
-21
-22
-24
-33
-48
-38
-33
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-3571.54%
-2165.56%
-3205.53%
-60269.14%
0.00%
-37652.22%

Actinium Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-9
-8
-11
-11
-6
-15
-6
-5
-5
Operating Cash Flow
-7
-7
-7
-11
-5
-7
-5
-6
-5
Investing Cash Flow
-
0
-
-
-
-
-
-
0
Financing Cash Flow
1
14
9
4
0
0
0
0
0
Change in Cash
-6
7
1
-7
-5
-7
-5
-6
-5

Actinium Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
-23
-21
-22
-24
-33
-48
-38
-33
Operating Cash Flow
-21
-20
-21
-21
-20
8
-47
-33
-24
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
18
16
17
76
35
23
14
29
0
Change in Cash
-3
-3
-4
54
14
31
-32
-3
-24

Insights on Actinium Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ATNM stock has moved up by 13.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BeOne Medicines Ltd has given 28.1% return, outperforming this stock by 38.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 19.1% return, outperforming this stock by 104.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 810.0K → 90.0K (in $), with an average decrease of 88.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -5.13M → -5.94M (in $), with an average decrease of 15.8% per quarter

About Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company offers Actimab-A, a CD33 targeting radiotherapeutic for patients with Relapsed/Refractory AML which is in to a Phase 2/3 Trial; and Iomab-ACT, to improve patient access to and outcomes with cellular therapies, such as CAR-T and gene therapies for non-malignant hematologic disorders such as sickle cell disease. It also develops ATNM-400, a antibody radioconjugate that deliver alpha-emitter Ac-225 to prostate cancer cellsIn addition, the company's Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia. Further, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies, and its research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company is based in New York, New York.
OrganisationActinium Pharmaceuticals Inc
Headquarters100 Park Avenue, New York, NY, United States, 10017
IndustryBiotechnology
CEOMr. Sandesh C. Seth M.B.A., M.S.
E-voting on sharesClick here to vote

Key Management of Actinium Pharmaceuticals Inc

Name

Title

Dr. Paul Diamond Esq., Ph.D.

Vice President of Patent & Legal Counsel

Ms. Lynn M. Bodarky M.B.A.

Chief Business Officer

Dr. Madhuri Vusirikala M.D.

Vice President of Clinical Development BMT & Cellular Therapy

Mr. Sandesh C. Seth M.B.A., M.S.

CEO, Principal Financial Officer & Chairman

FAQs

What is Actinium Pharmaceuticals Inc share price today?

Actinium Pharmaceuticals Inc share price today is $1.24 as on at the close of the market. Actinium Pharmaceuticals Inc share today touched a day high of $1.3 and a low of $1.23.

What is the 52 week high and 52 week low for Actinium Pharmaceuticals Inc share?

Actinium Pharmaceuticals Inc share touched a 52 week high of $1.95 on and a 52 week low of $0.95 on . Actinium Pharmaceuticals Inc stock price today i.e. is closed at $1.24,which is 36.26% down from its 52 week high and 30.25% up from its 52 week low.

What is Actinium Pharmaceuticals Inc's market capitalisation today?

Actinium Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Actinium Pharmaceuticals Inc Stock (ATNM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Actinium Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Actinium Pharmaceuticals Inc Shares that will get you 1.2097 shares as per Actinium Pharmaceuticals Inc share price of $1.24 per share as on May 7, 2026 at 1:29 am IST.

What is the minimum amount required to buy Actinium Pharmaceuticals Inc Stock (ATNM) from India?

Indian investors can start investing in Actinium Pharmaceuticals Inc (ATNM) shares with as little as ₹94.61 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.10 in Actinium Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Actinium Pharmaceuticals Inc share’s latest price of $1.24 as on May 7, 2026 at 1:29 am IST, you will get 8.0645 shares of Actinium Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Actinium Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Actinium Pharmaceuticals Inc stock has given -82.64% share price returns and 29.19% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?